Public data and open source tools for multi-assay genomic investigation of disease

Briefings in Bioinformatics

Volumn 17, Issue 4, 2016, Pages 603-615

  Kannan, Lavanya ^a   Ramos, Marcel ^a   Re, Angela ^b   El Hachem, Nehme ^c   Safikhani, Zhaleh ^d   Gendoo, Deena M A ^d   Davis, Sean ^e   Gomez Cabrero, David ^f   Castelo, Robert ^g   Hansen, Kasper D ^h   Carey, Vincent J ⁱ   Morgan, Martin ^j   Culhane, Aedín C ^k   Haibe Kains, Benjamin ^d   Waldron, Levi ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b UNIVERSITY OF TRENTO   (Italy)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UNIVERSITAT POMPEU FABRA   (Spain)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j ROSWELL PARK CANCER INSTITUTE   (United States)

^k DANA FARBER CANCER INSTITUTE   (United States)

more..

Author keywords

Bioconductor; Cancer; Integrative genomics; Multiple assays (multi assays); Omics; Pharmacogenomics; Public data

Indexed keywords

MICRORNA;

BIOLOGY; DNA SEQUENCE; GENOMICS;

COMPUTATIONAL BIOLOGY; GENOMICS; MICRORNAS; SEQUENCE ANALYSIS, DNA;

EID: 84991314240     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbv080     Document Type: Article

References (98)

1. Gomez-Cabrero D, Abugessaisa I, Maier D, et al. Data integration in the era of omics: current and future challenges. BMC Syst Biol 2014;8 (Suppl 2):I1.
2. International Cancer Genome Consortium, Hudson TJ, Anderson W, et al. International network of cancer genome projects. Nature 2010;464:993-8.
3. Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 2013;41:D991-5.
4. Kolesnikov N, Hastings E, Keays M, et al. ArrayExpress update-simplifying data submissions. Nucleic Acids Res 2015;43:D1113-6.
5. Hoadley KA, Yau C, Wolf DM, et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 2014;158:929-44.
6. Zhang B, Wang J, Wang X, et al. Proteogenomic characterization of human colon and rectal cancer. Nature 2014;513:382-7.
7. Yuan Y, Van Allen EM, Omberg L, et al. Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat Biotechnol 2014;32:644-52.
8. Samur MK. RTCGAToolbox: a new tool for exporting TCGA Firehose data. PLoS One 2014;9:e106397.
9. Broad Institute MIT. Firehose Broad GDAC Download. https://confluence.broadinstitute.org/display/GDAC/Download
10. Saleem M, Padmanabhuni SS, Ngomo A-CN, et al. Linked Cancer Genome Atlas Database. In: Proceedings of the 9th International Conference on Semantic Systems 2013, ACM, New York, NY, USA, pp. 129-34.
11. Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013;6:l1.
12. Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012;2:401-4.
13. Wilks C, Cline MS, Weiler E, et al. The Cancer Genomics Hub (CGHub): overcoming cancer through the power of torrential data. Database 2014;2014:bau093.
14. Zhu Y, Qiu P, Ji Y. TCGA-assembler: open-source software for retrieving and processing TCGA data. Nat Methods 2014;11:599-600
15. Bot B. Sage Bionetworks: Introduction to the Synapse Client. https://www.synapse.org/#!Wiki:syn1834618/ENTITY
16. National Cancer Institute. The Cancer Genome Atlas: Data Portal. https://tcga-data.nci.nih.gov/tcga/tcgaDownload.jsp
17. The Cancer Imaging Archive. About The Cancer Imaging Archive (TCIA). http://www.cancerimagingarchive. net/about-the-cancer-imaging-archive-tcia/
18. Curtis C, Shah SP, Chin S-F, et al. The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature 2012;486:346-52.
19. Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 2006;6:813-23.
20. Reinhold WC, Sunshine M, Liu H, et al. CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res 2012;72:3499-511.
21. Bussey KJ, Chin K, Lababidi S, et al. Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol Cancer Ther 2006;5:853-67.
22. Varma S, Pommier Y, Sunshine M, et al. High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner. PLoS One 2014;9:e92047.
23. Yu M, Selvaraj SK, Liang-Chu MMY, et al. A resource for cell line authentication, annotation and quality control. Nature 2015;520:307-11.
24. Barretina J, Caponigro G, Stransky N, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012;483:603-7.
25. Macconaill LE, Garraway LA. Clinical implications of the cancer genome. J Clin Oncol 2010;28:5219-28.
26. Garnett MJ, Edelman EJ, Heidorn SJ, et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012;483:570-5.
27. Basu A, Bodycombe NE, Cheah JH, et al. An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell 2013;154:1151-61.
28. Cheung HW, Cowley GS, Weir BA, et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci USA 2011;108:12372-7.
29. Cowley GS, Weir BA, Vazquez F, et al. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies. Scientific Data 2014;1:140035.
30. Jerby-Arnon L, Pfetzer N, Waldman YY, et al. Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality. Cell 2014;158:1199-209.
31. Aksoy BA, Demir E, BaburÖ, et al. Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles. Bioinformatics 2014;30:2051-9.
32. Nijhawan D, Zack TI, Ren Y, et al. Cancer vulnerabilities unveiled by genomic loss. Cell 2012;150:842-54.
33. Koh JLY, Brown KR, Sayad A, et al. COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines. Nucleic Acids Res 2012;40:D957-63.
34. Lamb J, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006;313:1929-35.
35. NIH, Broad Institute. The LINCS Connectivity Map Project. The LINCS Connectivity Map Project 2013;19:63-74.
36. Peck D, Crawford ED, Ross KN, et al. A method for highthroughput gene expression signature analysis. Genome Biol 2006;7:R61.
37. Duan Q, Flynn C, Niepel M, et al. LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures. Nucleic Acids Res 2014;42:W449-60.
38. Genomes Project Consortium, Abecasis GR, Auton A, et al. An integrated map of genetic variation from 1, 092 human genomes. Nature 2012;491:56-65.
39. Jefferis BJMH, Power C, Hertzman C. Birth weight, childhood socioeconomic environment, and cognitive development in the 1958 British birth cohort study. BMJ 2002;325:305.
40. Hyppönen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 2006;29:2244-6.
41. Viner RM, Cole TJ. Who changes body mass between adolescence and adulthood? Factors predicting change in BMI between 16 year and 30 years in the 1970 British Birth Cohort. Int J Obes 2006;30:1368-74.
42. Kaushal R, Hripcsak G, Ascheim DD, et al. Changing the research landscape: the New York City Clinical Data Research Network. J Am Med Inform Assoc 2014;21:587-90.
43. Rubin MA. Health: make precision medicine work for cancer care. Nature 2015;520:290-1.
44. Mailman MD, Feolo M, Jin Y, et al. The NCBI dbGaP database of genotypes and phenotypes. Nat Genet 2007;39:1181-6.
45. Lappalainen I, Almeida-King J, Kumanduri V, et al. The European Genome-phenome Archive of human data consented for biomedical research. Nat Genet 2015;47:692-5.
46. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489:57-74.
47. Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature 2012;489:101-8.
48. Neph S, Vierstra J, Stergachis AB, et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 2012;489:83-90.
49. Thurman RE, Rynes E, Humbert R, et al. The accessible chromatin landscape of the human genome. Nature 2012;489:75-82.
50. Mouse ENCODE Consortium, Stamatoyannopoulos JA, Snyder M, et al. An encyclopedia of mouse DNA elements (Mouse ENCODE). Genome Biol 2012;13:418.
51. Boyle AP, Araya CL, Brdlik C, et al. Comparative analysis of regulatory information and circuits across distant species. Nature 2014;512:453-6.
52. Michailidou K, Beesley J, Lindstrom S, et al. Genome-wide association analysis of more than 120, 000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet 2015;47:373-80.
53. Lo KA, Labadorf A, Kennedy NJ, et al. Analysis of in vitro insulin-resistance models and their physiological relevance to in vivo diet-induced adipose insulin resistance. Cell Rep 2013;5:259-70.
54. Susztak K. Understanding the epigenetic syntax for the genetic alphabet in the kidney. J Am Soc Nephrol 2014;25:10-17.
55. Lettre G, Rioux JD. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008;17:R116-21.
56. Andersson R, Gebhard C, Miguel-Escalada I, et al. An atlas of active enhancers across human cell types and tissues. Nature 2014;507:455-61.
57. FANTOM Consortium and the RIKEN PMI and CLST (DGT), Forrest ARR, Kawaji H, et al. A promoter-level mammalian expression atlas. Nature 2014;507:462-70.
58. Arner E, Daub CO, Vitting-Seerup K, et al. Gene regulation. Transcribed enhancers lead waves of coordinated transcription in transitioningmammalian cells. Science 2015;347:1010-14.
59. Lizio M, Harshbarger J, Shimoji H, et al. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol 2015;16:22.
60. Zerbino DR, Wilder SP, Johnson N, et al. The ensembl regulatory build. Genome Biol 2015;16:56.
61. Zhu Y, Davis S, Stephens R, et al. GEOmetadb: powerful alternative search engine for the Gene Expression Omnibus. Bioinformatics 2008;24:2798-800.
62. Wickham H, Francois R. dplyr: A Grammar of Data Manipulation. 2015.
63. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
64. Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 2007;23:1846-7.
65. Parkinson H, Kapushesky M, Shojatalab M, et al. ArrayExpress-a public database of microarray experiments and gene expression profiles. Nucleic Acids Res 2006; 35:D747-50.
66. Kauffmann A, Rayner TF, Parkinson H, et al. Importing ArrayExpress datasets into R/Bioconductor. Bioinformatics 2009;25:2092-4.
67. Gilad Y, Rifkin SA, Pritchard JK. Revealing the architecture of gene regulation: the promise of eQTL studies. Trends Genet 2008;24:408-15.
68. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet 2013;45:580-5.
69. The GTEx Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 2015;348:648-60.
70. Pennisi E. New database links regulatory DNA to its target genes. Science 2015;348:618-19.
71. Ferreiró s-Vidal I, Carroll T, Taylor B, et al. Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation. Blood 2013;121:1769-82.
72. Ganzfried BF, Riester M, Haibe-Kains B, et al. curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome. Database 2013;2013:bat013.
73. Schroeder MP, Gonzalez-Perez A, Lopez-Bigas N. Visualizing multidimensional cancer genomics data. Genome Med 2013;5:9.
74. Goldman M, Craft B, Swatloski T, et al. The UCSC Cancer Genomics Browser: update 2015. Nucleic Acids Res 2015;43:D812-7.
75. Fiume M, Smith EJM, Brook A, et al. Savant Genome Browser 2: visualization and analysis for population-scale genomics. Nucleic Acids Res 2012;40:W615-21.
76. Thorvaldsdó ttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 2013;14:178-92.
77. Chelaru F, Smith L, Goldstein N, et al. Epiviz: interactive visual analytics for functional genomics data. Nat Methods 2014;11:938-40.
78. Krzywinski M, Schein J, Birol I, et al. Circos: an information aesthetic for comparative genomics. Genome Res 2009;19:1639-45.
79. Gu Z, Gu L, Eils R, et al. circlize Implements and enhances circular visualization in R. Bioinformatics 2014;30:2811-12.
80. Gundem G, Perez-Llamas C, Jene-Sanz A, et al. IntOGen: integration and data mining of multidimensional oncogenomic data. Nat Methods 2010;7:92-3.
81. Rubio-Perez C, Tamborero D, Schroeder MP, et al. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. Cancer Cell 2015;27:382-96.
82. Turkay C, Lex A, Streit M, et al. Characterizing cancer subtypes using dual analysis in Caleydo StratomeX. IEEE Comput. Graph Appl 2014;34:38-47.
83. Perez-Llamas C, Lopez-Bigas N. Gitools: analysis and visualisation of genomic data using interactive heat-maps. PLoS One 2011;6:e19541.
84. Lawrence M, Huber W, Pagès H, et al. Software for computing and annotating genomic ranges. PLoS Comput Biol 2013;9:e1003118.
85. Gautier L, Cope L, Bolstad BM, et al. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004;20:307-15.
86. Leek JT, Scharpf RB, Bravo HC, et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet 2010;11:733-9.
87. Culhane AC, Perriè re G, Higgins DG. Cross-platform comparison and visualisation of gene expression data using coinertia analysis. BMC Bioinformatics 2003;4:59.
88. Meng C, Kuster B, Culhane AC, et al. A multivariate approach to the integration of multi-omics datasets. BMC Bioinformatics 2014;15:162.
89. Tenenhaus A, Philippe C, Guillemot V, et al. Variable selection for generalized canonical correlation analysis. Biostatistics 2014;15:569-83.
90. Jansen R, Greenbaum D, Gerstein M. Relating whole-genome expression data with protein-protein interactions. Genome Res 2002;12:37-46.
91. Ideker T, Ozier O, Schwikowski B, et al. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 2002;18 (Suppl 1):S233-40.
92. Guo Z, Wang L, Li Y, et al. Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network. Bioinformatics 2007;23:2121-8.
93. Louhimo R, Hautaniemi S. CNAmet: an R package for integrating copy number, methylation and expression data. Bioinformatics 2011;27:887-8.
94. Tyekucheva S, Marchionni L, Karchin R, et al. Integrating diverse genomic data using gene sets. Genome Biol 2011;12:R105.
95. Shen R, Wang S, Mo Q. Sparse integrative clustering of multiple omics data sets. Ann Appl Stat 2013;7:269-94.
96. Huber W, Carey VJ, Gentleman R, et al. Orchestrating highthroughput genomic analysis with Bioconductor. Nat Methods 2015;12:115-21.
97. Witten DM, Tibshirani R, Hastie T. A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. Biostatistics 2009;10:515-34.
98. Liquet B, LêCao K-A, Hocini H, et al. A novel approach for biomarker selection and the integration of repeated measures experiments from two assays. BMC Bioinformatics 2012;13:325.